Market Overview

Benzinga's Top Pre-Market Losers

Related GILD
Gilead Gets European CHMP's Positive Opinion On Its Type II Variation Application For Truvada
Here Are The 14 Stocks Morgan Stanley Wants You To Focus On During Q2 Earnings
5 Big Drugmakers Reporting Earnings Next Week (Investor's Business Daily)
Related CROX
Watch These 7 Huge Call Purchases In Friday Trade
Watch These 5 Huge Put Purchases In Tuesday Trade
Shaky earnings roil apparel and footwear stocks (Seeking Alpha)

Gilead Sciences (NASDAQ: GILD) dipped 2.40% to $58.66 in the pre-market session. Gilead Sciences shares have jumped 124.40% over the past 52 weeks, while the S&P 500 index has gained 25.09% in the same period.

Crocs (NASDAQ: CROX) shares fell 2.09% to $16.40 in the pre-market trading after Wedbush downgraded the stock from “outperform” to “neutral.”

Broadcom (NASDAQ: BRCM) shares dropped 1.45% to $33.20 in pre-market trading. Broadcom's trailing-twelve-month ROA is 4.58%.

Honeywell International (NYSE: HON) dipped 0.49% to $83.16 in the pre-market session after Nomura downgraded the stock from “buy” to “neutral.”

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (BRCM + CROX)

View Comments and Join the Discussion!